X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs DISHMAN PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD DISHMAN PHARMA MERCK LTD/
DISHMAN PHARMA
 
P/E (TTM) x 34.2 25.1 136.2% View Chart
P/BV x 3.8 3.3 114.3% View Chart
Dividend Yield % 0.7 0.7 111.3%  

Financials

 MERCK LTD   DISHMAN PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-16
DISHMAN PHARMA
Mar-16
MERCK LTD/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,060374 283.1%   
Low Rs623129 483.3%   
Sales per share (Unadj.) Rs632.4197.8 319.7%  
Earnings per share (Unadj.) Rs45.721.2 215.6%  
Cash flow per share (Unadj.) Rs62.334.7 179.5%  
Dividends per share (Unadj.) Rs11.002.00 550.0%  
Dividend yield (eoy) %1.30.8 164.5%  
Book value per share (Unadj.) Rs388.8179.9 216.1%  
Shares outstanding (eoy) m16.6080.69 20.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.31.3 104.6%   
Avg P/E ratio x18.411.9 155.1%  
P/CF ratio (eoy) x13.57.2 186.3%  
Price / Book Value ratio x2.21.4 154.7%  
Dividend payout %24.19.4 255.1%   
Avg Mkt Cap Rs m13,96920,306 68.8%   
No. of employees `0001.60.8 191.0%   
Total wages/salary Rs m1,4875,355 27.8%   
Avg. sales/employee Rs Th6,631.919,252.7 34.4%   
Avg. wages/employee Rs Th939.26,459.5 14.5%   
Avg. net profit/employee Rs Th479.42,064.1 23.2%   
INCOME DATA
Net Sales Rs m10,49815,961 65.8%  
Other income Rs m242265 91.3%   
Total revenues Rs m10,74116,226 66.2%   
Gross profit Rs m1,1354,103 27.7%  
Depreciation Rs m2761,091 25.3%   
Interest Rs m0944 0.0%   
Profit before tax Rs m1,1022,334 47.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m343624 55.1%   
Profit after tax Rs m7591,711 44.4%  
Gross profit margin %10.825.7 42.1%  
Effective tax rate %31.126.7 116.6%   
Net profit margin %7.210.7 67.4%  
BALANCE SHEET DATA
Current assets Rs m6,41011,018 58.2%   
Current liabilities Rs m8,8289,517 92.8%   
Net working cap to sales %-23.09.4 -245.0%  
Current ratio x0.71.2 62.7%  
Inventory Days Days58110 52.2%  
Debtors Days Days3835 110.2%  
Net fixed assets Rs m1,40616,304 8.6%   
Share capital Rs m166161 102.9%   
"Free" reserves Rs m6,28612,907 48.7%   
Net worth Rs m6,45514,516 44.5%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m8,82829,805 29.6%  
Interest coverage xNM3.5-  
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.20.5 222.1%   
Return on assets %8.68.9 96.5%  
Return on equity %11.811.8 99.7%  
Return on capital %17.117.5 97.4%  
Exports to sales %8.324.8 33.4%   
Imports to sales %21.03.7 563.2%   
Exports (fob) Rs m8693,956 22.0%   
Imports (cif) Rs m2,209596 370.5%   
Fx inflow Rs m9594,952 19.4%   
Fx outflow Rs m2,612697 374.9%   
Net fx Rs m-1,6534,255 -38.9%   
CASH FLOW
From Operations Rs m1,0702,786 38.4%  
From Investments Rs m-750-1,529 49.0%  
From Financial Activity Rs m-150-941 15.9%  
Net Cashflow Rs m171316 54.0%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 51.8 0.0 -  
Indian inst/Mut Fund % 18.2 3.7 491.9%  
FIIs % 1.0 12.7 7.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 22.1 131.7%  
Shareholders   28,591 46,261 61.8%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   PLETHICO PHARMA  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  ELDER PHARMA  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Market at Record Highs; Strong ITC & RIL Performance & Other Top Cues to Sway the Market Today(Pre-Open)

Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services. At the closing bell last week.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Jan 22, 2018 09:43 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MERCK LTD 8-QTR ANALYSIS

COMPARE MERCK LTD WITH

MARKET STATS